Home > Products > CD33 & CD16
> Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (sdAb-IgG)
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (sdAb-IgG) (CAT#: BSSG-389)
Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (sdAb-IgG) is formed by an IgG and two single domains antibodies (sdAbs). The sdAbs from an anti-CD16 antibody variable domain are respectively connected to the N terminus of the anti-CD33 IgG heavy chains or light chains to form sdAb-(H)IgG or sdAb-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-CD16 Bispecific Antibody (sdAb-IgG) (BSSG-389). Click the button below to contact us or submit your feedback about this product.